65 related articles for article (PubMed ID: 21964930)
1. Osteocalcin gene expression is regulated by wild-type p53.
Chen H; Hays E; Liboon J; Neely C; Kolman K; Chandar N
Calcif Tissue Int; 2011 Nov; 89(5):411-8. PubMed ID: 21964930
[TBL] [Abstract][Full Text] [Related]
2. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
3. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
Li C; Lin M; Liu J
Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
[TBL] [Abstract][Full Text] [Related]
4. Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53.
Chandar N; Swindle J; Szajkovics A; Kolman K
J Orthop Res; 2005 Nov; 23(6):1345-53. PubMed ID: 15994055
[TBL] [Abstract][Full Text] [Related]
5. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation.
Heinrichs AA; Banerjee C; Bortell R; Owen TA; Stein JL; Stein GS; Lian JB
J Cell Biochem; 1993 Nov; 53(3):240-50. PubMed ID: 8263041
[TBL] [Abstract][Full Text] [Related]
8. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: minimal role of the proximal E-box cis-acting promoter elements.
Quarles LD; Siddhanti SR; Medda S
J Cell Biochem; 1997 Apr; 65(1):11-24. PubMed ID: 9138076
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new pebp2alphaA2 isoform from zebrafish runx2 capable of inducing osteocalcin gene expression in vitro.
Pinto JP; Conceição NM; Viegas CS; Leite RB; Hurst LD; Kelsh RN; Cancela ML
J Bone Miner Res; 2005 Aug; 20(8):1440-53. PubMed ID: 16007341
[TBL] [Abstract][Full Text] [Related]
11. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
12. Induction of p53 expression and function by estrogen in osteoblasts.
Bovenkerk S; Lanciloti N; Chandar N
Calcif Tissue Int; 2003 Sep; 73(3):274-80. PubMed ID: 14667141
[TBL] [Abstract][Full Text] [Related]
13. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
14. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.
Wei X; Xu H; Kufe D
Cancer Cell; 2005 Feb; 7(2):167-78. PubMed ID: 15710329
[TBL] [Abstract][Full Text] [Related]
15. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
16. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
17. Mitofusin-2 is a novel direct target of p53.
Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
[TBL] [Abstract][Full Text] [Related]
18. p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.
Zhang DW; Jeang KT; Lee CG
Oncogene; 2006 Apr; 25(16):2318-27. PubMed ID: 16501612
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina.
Wallace DM; Cotter TG
J Neurosci Res; 2009 Mar; 87(4):887-905. PubMed ID: 18951482
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
